NCT06094738 - A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2020

Primary Completion Date

November 16, 2020

Study Completion Date

November 16, 2020

Conditions

Healthy

Interventions

DRUG

Relacorilant under fasted conditions

Oral relacorilant 400 mg (4 X 100 mg softgel capsules) single dose on Day 1 under fasted conditions

DRUG

Relacorilant after a high-fat meal

Oral relacorilant 400 mg (4 X 100 mg softgel capsules) single dose on Day 1 after a high-fat meal

DRUG

Relacorilant after a low-fat meal

Oral relacorilant 400 mg (4 X 100 mg softgel capsules) single dose on Day 1 after a low-fat meal

Trial Locations (1)

inVentiv Health Clinical Research Services LLC, Miami